Skip to Content
Contact DCTD
Show menu
Search this site
Last Updated: 12/08/2017

Funding Opportunity Announcements (FOAs)

Funding Opportunities through DCTD’s Programs

Visit the websites of DCTD's individual programs for more information on currently available funding opportunities.

DCTD-related Cancer Moonshot Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Pediatric Immunotherapy Discovery and Development Network (PI-DDN) RFA-CA-17-050 November 19, 2017 December 20, 2017 U54
Pediatric Immunotherapy Discovery and Development Network (PI-DDN) RFA-CA-17-051 November 19, 2017 December 20, 2017 U01
Mechanism of Cancer Drug Resistance and Sensitivity: Coordinating Center RFA-CA-17-044 December 5, 2017 January 6, 2018 U24
Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects RFA-CA-17-045 December 16, 2017 January 17, 2018 U01
Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) RFA-CA-17-048 December 16, 2017 January 17, 2018 U24
Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer PA-17-138 March 1, 2017 March 29, 2018 Admin Supp
Gene Fusions in Pediatric Sarcomas PA-16-251 September 15, 2017 May 8, 2019 R01
Gene Fusions in Pediatric Sarcomas PA-16-252 September 16, 2017 May 8, 2019 R21
Discovery of Small Molecule Immunomodulators for Cancer Therapy PAR-17-331 September 5, 2017 September 8, 2020 R01
Trans-DCTD Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
NCI Clinical and Translational Exploratory/Developmental Studies PAR-16-176 June 16,
2016
March 23,
2019
R21
Early Phase Clinical Trials in Imaging and Image-Guided Interventions PAR-17-167 May 28,
2017
February 15,
2020
R01
DCTD-related Trans-NCI Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Minority Patient-Derived Xenograft (PDX) Development and Trial Centers (M-PDTCs) RFA-CA-17-032 December 18,
2017
January 19,
2018
U54
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities RFA-CA-17-033 December 18,
2017
January 19,
2018
P20
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine PAR-16-385 October 17,
2016
June 15,
2018
U24
Imaging and Biomarkers for Early Detection of Aggressive Cancer PAR-16-089 June 11,
2016
December 12,
2018
U01
Revision Applications for Validation of Biomarker Assays Developed through NIH-Supported Research Grants PAR-17-003 January 28,
2017
October 29,
2019
R01
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-18-317
PAR-18-310
January 14,
2018
October 9,
2020
UH2/UH3
UH3
DCTD-related Trans-NIH Funding Opportunities
Title Announcement Number Opening
Date
Expiration Date Activity Code
Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment PAR-15-075 February 6,
2015
January 8,
2018
R01
Bioengineering Research Partnerships PAR-16-116 April 18,
2016
January 24,
2018
U01
Bioengineering Research Grants PAR-16-242 May 10,
2016
January 24,
2018
R01
Image-guided Drug Delivery PAR-16-044 May 21,
2016
November 23,
2018
R01
Serious Adverse Drug Reaction Research PAR-16-274
PAR-16-275
September 4,
2016
September 8,
2019
R21
R01
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems PAR-17-093 February 1,
2017
November 6,
2019
R01
Assay Development and Screening for Discovery of Chemical Probes or Therapeutic Agents PAR-17-438 September 5,
2017
September 8,
2020
R01